CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in RCUS — Arcus Biosciences, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in RCUS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$19,518,580
-$3,554,603 QoQ
Shares Held
903,638
-6.7% QoQ
Ownership
0.718%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.99114689731951.ToString("F0")%
Shared 0.ToString("F0")%
None 0.008853102680498165.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,181,979,796 across 287 Biotechnology names. RCUS ranks #60 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in RCUS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,518,580 | 903,638 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,073,183 | 968,241 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,847,640 | 871,150 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,322,679 | 776,742 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,604,915 | 714,002 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $8,630,586 | 579,623 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $8,669,108 | 566,979 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,728,356 | 507,443 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,313,050 | 493,276 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,018,676 | 472,182 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $8,272,095 | 460,841 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,870,209 | 436,741 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $7,691,643 | 421,691 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,038,729 | 388,720 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,917,099 | 379,094 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,698,740 | 343,281 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,435,345 | 330,651 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $13,037,410 | 322,150 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $12,387,253 | 355,241 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $9,461,590 | 344,559 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,358,249 | 333,271 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,452,596 | 287,080 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,850,157 | 282,973 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,339,699 | 256,253 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $2,723,825 | 196,241 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||